A double‐blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis von Green, J. R. B., Mansfield, J. C., Gibson, J. A., Kerr, G. D., Thornton, P. C.

Volltext

Omeprazole is more effective than cimetidine for the relief of all grades of gastro‐oesophageal reflux disease‐associated heartburn, irrespective of the presence or absence of endo... von BATE, C. M., GREEN, J. R. B., AXON, A. T. R., MURRAY, F. E., TILDESLEY, G., EMMAS, C. E., TAYLOR, M. D.

Volltext

Patient‐led variable dosing with balsalazide as long‐term therapy for maintenance in ulcerative colitis: a 3‐year prospective observational study von Green, J. R. B., Swan, C. H. J., Gibson, J. A., Kerr, G. D., Swarbrick, E. T., Thornton, P. C.

Volltext

Biliary boulders von Steed, H, Lau, K, Glass, R, Durkin, D, Deakin, M, Green, J R B

Volltext

Collagenous Colitis Responsive to Octreotide Therapy von Fisher, N C, Tutt, A, Sim, E, Scarpello, J H. B, Green, J R. B

Volltext

Maintenance of Crohn’s disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules von Green, J. R. B., Lobo, A. J., Giaffer, M., Travis, S., Watkins, H. C.

Volltext

Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation von A Flynn, R. B. Pedley, A. J. Green, G. M. Boxer, R. Boden, J. Dearling, J. Bhatia, R. H. J. Begent, A.

Volltext

Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double‐blind, randomized trial von BELL, G. D., BATE, C. M., AXON, A. T. R., TILDESLEY, G., KERR, G. D., GREEN, J. R. B., EMMAS, C. E., TAYLOR, M. D.

Volltext

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis von Green, Jonathan R.B., Lobo ‡, Alan J., Holdsworth ‡, Charles D., Leicester §, Roger J., Gibson ∥, John A., Kerr ¶, Graeme D., Hodgson #, Humphrey J.F., Parkins, Katharine J., Taylor, Michael D.

Volltext

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months von GREEN, J. R. B, GIBSON, J. A, KERR, G. D, SWARBRICK, E. T, LOBO, A. J, HOLDSWORTH, C. D, CROWE, J. P, SCHOFIELD, K. J, TAYLOR, M. D

Volltext

The effects of flumazenil on alertness and hypoxia in elderly patients after ERCP von HAINES, D. J., BIBBEY, D., GREEN, J. R. B.

Volltext

Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease von Pearce, Callum B, Duncan, Hamish D, Timmis, Lynne, Green, Jonathan R. B

Volltext

Sensorineural hearing loss in ulcerative colitis von Kumar, B.N., Smith, M.S.H., Walsh, R.M., Green, J.R.B.

Volltext

Enteral Feeds May Antagonise Warfarin von Watson, A. J. M., Pegg, M., Green, J. R. B.

Volltext

Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine von McFarland, R.J., Bateson, M.C., Green, J.R.B., O'Donoghue, D.P., Dronfield, M.W., Keeling, P.W.N., Burke, G.J., Dickinson, R.J., Shreeve, D.R., Peers, E.M., Richardson, P.D.I.

Volltext

Reply von Green, J R B

Volltext

Reply von Green, J R B

Volltext

Reply von Green, J R B

Volltext

Reply von Green, J R B

Volltext

Balsalazide von PRAKASH, A, SPENCER, C. M, GREEN, J. R. B, MANSFIELD, J. C

Volltext